Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Combining proper shaving, topical treatments, and laser therapy effectively reduces Pseudofolliculitis Barbae.

Three new techniques simplify and improve the preparation of tissue samples for skin cancer surgery.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

African hair has the most lipids, while Caucasian hair is more hydrated and stronger.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Dermoscopy helps quickly identify hair breakage in people of African descent.

Human hair varies widely and should be classified by curl type rather than race.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Widened sweat ducts are a very specific sign of scarring hair loss.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

Lipids in Japanese hair help maintain glossiness and structure.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.